Correlation Between Monte Rosa and Biomea Fusion

Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Biomea Fusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Biomea Fusion into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Monte Rosa Therapeutics and Biomea Fusion, you can compare the effects of market volatilities on Monte Rosa and Biomea Fusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Biomea Fusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Biomea Fusion.

Diversification Opportunities for Monte Rosa and Biomea Fusion

0.16

Correlation Coefficient

Monte Rosa  Biomea Fusion

Average diversification

The 3 months correlation between Monte and Biomea is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Biomea Fusion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomea Fusion and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Biomea Fusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomea Fusion has no effect on the direction of Monte Rosa i.e., Monte Rosa and Biomea Fusion go up and down completely randomly.

Pair Corralation between Monte Rosa and Biomea Fusion

Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 1.07 times more return on investment than Biomea Fusion. However, Monte Rosa is 1.07 times more volatile than Biomea Fusion. It trades about -0.08 of its potential returns per unit of risk. Biomea Fusion is currently generating about -0.14 per unit of risk. If you would invest  702.00  in Monte Rosa Therapeutics on December 28, 2024 and sell it today you would lose (176.00) from holding Monte Rosa Therapeutics or give up 25.07% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Monte Rosa Therapeutics  vs.  Biomea Fusion

Monte Rosa Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Monte Rosa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Biomea Fusion

Risk-Adjusted Performance

Very Weak

Over the last 90 days Biomea Fusion has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Monte Rosa and Biomea Fusion

The main advantage of trading using opposite Monte Rosa and Biomea Fusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Biomea Fusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomea Fusion will offset losses from the drop in Biomea Fusion's long position.

The idea behind Monte Rosa Therapeutics and Biomea Fusion pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.